| GC36838-500μg |
|
— |
PACAP (1-38), human, ovine, rat TFA
|
0 |
C203H331N63O53S.C2HF3O2 |
|
|
|
| GC36837-100mg |
|
939983-14-9 |
p53 and MDM2 proteins-interaction-inhibitor racemic
|
0 |
C40H49Cl2N5O4 |
|
|
|
| GC36837-10mg |
|
939983-14-9 |
p53 and MDM2 proteins-interaction-inhibitor racemic
|
0 |
C40H49Cl2N5O4 |
|
|
|
| GC36836-100mg |
|
— |
p53 and MDM2 proteins-interaction-inhibitor dihydrochloride
|
0 |
C40H51Cl4N5O4 |
|
|
|
| GC36836-10mg |
|
— |
p53 and MDM2 proteins-interaction-inhibitor dihydrochloride
|
0 |
C40H51Cl4N5O4 |
|
|
|
| GC36835-100mg |
|
939981-37-0 |
p53 and MDM2 proteins-interaction-inhibitor chiral
|
0 |
C40H49Cl2N5O4 |
|
|
|
| GC36835-10mg |
|
939981-37-0 |
p53 and MDM2 proteins-interaction-inhibitor chiral
|
0 |
C40H49Cl2N5O4 |
|
|
|
| GC36835-10mM (in 1mL DMSO) |
|
939981-37-0 |
p53 and MDM2 proteins-interaction-inhibitor chiral
|
0 |
C40H49Cl2N5O4 |
|
|
|
| GC36833-5mg |
|
802555-85-7 |
|
0 |
C23H28N8O2 |
|
|
|
| GC36833-1mg |
|
802555-85-7 |
|
0 |
C23H28N8O2 |
|
|
|
| GC36832-100mg |
|
1595129-71-7 |
|
0 |
C31H40N8O3S |
|
|
|
| GC36832-50mg |
|
1595129-71-7 |
|
0 |
C31H40N8O3S |
|
|
|
| GC36832-10mg |
|
1595129-71-7 |
|
0 |
C31H40N8O3S |
|
|
|
| GC36832-5mg |
|
1595129-71-7 |
|
0 |
C31H40N8O3S |
|
|
|
| GC36832-10mM (in 1mL DMSO) |
|
1595129-71-7 |
|
0 |
C31H40N8O3S |
|
|
|
| GC36831-100mg |
|
189224-26-8 |
|
0 |
C13H11N2NaO2 |
|
|
|
| GC36831-50mg |
|
189224-26-8 |
|
0 |
C13H11N2NaO2 |
|
|
|
| GC36831-5mg |
|
189224-26-8 |
|
0 |
C13H11N2NaO2 |
|
|
|
| GC36831-10 mM ( 1 mL in Water) |
|
189224-26-8 |
|
0 |
C13H11N2NaO2 |
|
|
|
| GC36829-5mg |
|
549-21-3 |
|
0 |
C20H17NO5 |
|
|
|
